UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM N-Q |
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY |
Investment Company Act file number: | (811-07513) |
Exact name of registrant as specified in charter: | Putnam Fund Trust |
Address of principal executive offices: | One Post Office Square, Boston, Massachusetts 02109 |
Name and address of agent for service: | Robert T. Burns, Vice President One Post Office Square Boston, Massachusetts 02109 |
Copy to: | Bryan Chegwidden, Esq. Ropes & Gray LLP 1211 Avenue of the Americas New York, New York 10036 |
Registrant's telephone number, including area code: | (617) 292-1000 |
Date of fiscal year end: | June 30, 2017 |
Date of reporting period: | March 31, 2017 |
Item 1. Schedule of Investments: |
Putnam Small Cap Growth Fund | ||||||
The fund's portfolio | ||||||
3/31/17 (Unaudited) | ||||||
COMMON STOCKS (98.3%)(a) | ||||||
Shares | Value | |||||
Aerospace and defense (0.8%) | ||||||
Kratos Defense & Security Solutions, Inc.(NON) | 52,041 | $404,879 | ||||
Orbital ATK, Inc. | 8,300 | 813,400 | ||||
1,218,279 | ||||||
Airlines (1.1%) | ||||||
Hawaiian Holdings, Inc.(NON) | 11,900 | 552,755 | ||||
JetBlue Airways Corp.(NON) | 21,500 | 443,115 | ||||
Spirit Airlines, Inc.(NON) | 13,300 | 705,831 | ||||
1,701,701 | ||||||
Auto components (0.6%) | ||||||
Cooper-Standard Holding, Inc.(NON) | 8,007 | 888,217 | ||||
888,217 | ||||||
Banks (3.7%) | ||||||
Bank of the Ozarks, Inc.(S) | 15,200 | 790,552 | ||||
Customers Bancorp, Inc.(NON) | 22,636 | 713,713 | ||||
FCB Financial Holdings, Inc. Class A(NON) | 18,584 | 920,837 | ||||
First BanCorp. (Puerto Rico)(NON) | 162,601 | 918,696 | ||||
Pinnacle Financial Partners, Inc. | 2,260 | 150,177 | ||||
Texas Capital Bancshares, Inc.(NON) | 5,400 | 450,630 | ||||
Webster Financial Corp. | 12,000 | 600,480 | ||||
Western Alliance Bancorp(NON) | 20,952 | 1,028,534 | ||||
5,573,619 | ||||||
Biotechnology (7.6%) | ||||||
ACADIA Pharmaceuticals, Inc.(NON)(S) | 11,065 | 380,415 | ||||
Acceleron Pharma, Inc.(NON) | 3,700 | 97,939 | ||||
Alder Biopharmaceuticals, Inc.(NON)(S) | 12,900 | 268,320 | ||||
Alkermes PLC(NON) | 7,100 | 415,350 | ||||
Ardelyx, Inc.(NON) | 23,427 | 296,352 | ||||
Array BioPharma, Inc.(NON)(S) | 43,600 | 389,784 | ||||
Axovant Sciences, Ltd. (Bermuda)(NON)(S) | 10,000 | 149,400 | ||||
Biospecifics Technologies Corp.(NON) | 10,553 | 578,304 | ||||
ChemoCentryx, Inc.(NON) | 24,400 | 177,632 | ||||
Clovis Oncology, Inc.(NON) | 12,400 | 789,508 | ||||
CytomX Therapeutics, Inc.(NON) | 28,300 | 488,741 | ||||
Eagle Pharmaceuticals, Inc.(NON)(S) | 8,259 | 685,001 | ||||
Emergent BioSolutions, Inc.(NON) | 15,223 | 442,076 | ||||
Exelixis, Inc.(NON) | 23,600 | 511,412 | ||||
FivePrime Therapeutics, Inc.(NON) | 10,627 | 384,166 | ||||
Halozyme Therapeutics, Inc.(NON)(S) | 24,613 | 318,984 | ||||
Kite Pharma, Inc.(NON)(S) | 8,700 | 682,863 | ||||
Lexicon Pharmaceuticals, Inc.(NON)(S) | 18,200 | 260,988 | ||||
Ligand Pharmaceuticals, Inc.(NON) | 4,449 | 470,882 | ||||
MiMedx Group, Inc.(NON) | 65,914 | 628,160 | ||||
Neurocrine Biosciences, Inc.(NON) | 7,586 | 328,474 | ||||
Portola Pharmaceuticals, Inc.(NON) | 7,118 | 278,954 | ||||
Prothena Corp. PLC (Ireland)(NON)(S) | 10,734 | 598,850 | ||||
Puma Biotechnology, Inc.(NON)(S) | 10,900 | 405,480 | ||||
Repligen Corp.(NON) | 20,292 | 714,278 | ||||
Sage Therapeutics, Inc.(NON) | 5,734 | 407,515 | ||||
Ultragenyx Pharmaceutical, Inc.(NON)(S) | 7,400 | 501,572 | ||||
11,651,400 | ||||||
Building products (2.1%) | ||||||
Continental Building Products, Inc.(NON) | 32,521 | 796,765 | ||||
NCI Building Systems, Inc.(NON) | 25,974 | 445,454 | ||||
Patrick Industries, Inc.(NON) | 10,901 | 772,881 | ||||
PGT Innovations, Inc.(NON) | 110,695 | 1,189,971 | ||||
3,205,071 | ||||||
Capital markets (0.9%) | ||||||
E*Trade Financial Corp.(NON) | 20,700 | 722,223 | ||||
Lazard, Ltd. Class A | 13,048 | 600,078 | ||||
1,322,301 | ||||||
Chemicals (2.9%) | ||||||
American Vanguard Corp. | 25,471 | 422,819 | ||||
FMC Corp. | 13,400 | 932,506 | ||||
Innophos Holdings, Inc. | 8,562 | 462,091 | ||||
Koppers Holdings, Inc.(NON) | 14,700 | 622,545 | ||||
Minerals Technologies, Inc. | 7,512 | 575,419 | ||||
Trinseo SA | 11,177 | 749,977 | ||||
W.R. Grace & Co. | 9,800 | 683,158 | ||||
4,448,515 | ||||||
Commercial services and supplies (2.0%) | ||||||
CECO Environmental Corp. | 23,500 | 246,985 | ||||
Deluxe Corp. | 5,259 | 379,542 | ||||
MSA Safety, Inc. | 9,728 | 687,672 | ||||
Stericycle, Inc.(NON) | 9,400 | 779,166 | ||||
Tetra Tech, Inc. | 22,571 | 922,025 | ||||
3,015,390 | ||||||
Communications equipment (3.0%) | ||||||
Applied Optoelectronics, Inc.(NON)(S) | 13,700 | 769,255 | ||||
Arista Networks, Inc.(NON) | 6,000 | 793,620 | ||||
Ciena Corp.(NON) | 18,881 | 445,780 | ||||
InterDigital, Inc./PA | 8,897 | 767,811 | ||||
Netscout Systems, Inc.(NON) | 20,500 | 777,975 | ||||
Plantronics, Inc. | 8,461 | 457,825 | ||||
Ubiquiti Networks, Inc.(NON)(S) | 10,676 | 536,576 | ||||
4,548,842 | ||||||
Construction and engineering (4.3%) | ||||||
AECOM(NON) | 21,300 | 758,067 | ||||
Argan, Inc. | 8,943 | 591,579 | ||||
Dycom Industries, Inc.(NON)(S) | 8,605 | 799,835 | ||||
Granite Construction, Inc. | 11,400 | 572,166 | ||||
MasTec, Inc.(NON) | 35,990 | 1,441,400 | ||||
Primoris Services Corp. | 13,500 | 313,470 | ||||
Quanta Services, Inc.(NON) | 31,900 | 1,183,809 | ||||
Tutor Perini Corp.(NON) | 27,700 | 880,860 | ||||
6,541,186 | ||||||
Construction materials (1.8%) | ||||||
Summit Materials, Inc. Class A(NON) | 59,910 | 1,480,376 | ||||
U.S. Concrete, Inc.(NON)(S) | 18,584 | 1,199,597 | ||||
2,679,973 | ||||||
Consumer finance (0.7%) | ||||||
Encore Capital Group, Inc.(NON)(S) | 8,279 | 254,993 | ||||
SLM Corp.(NON) | 62,500 | 756,250 | ||||
1,011,243 | ||||||
Diversified telecommunication services (0.9%) | ||||||
Cogent Communications Holdings, Inc. | 22,537 | 970,218 | ||||
Vonage Holdings Corp.(NON) | 51,200 | 323,584 | ||||
1,293,802 | ||||||
Electrical equipment (1.6%) | ||||||
AZZ, Inc. | 7,655 | 455,473 | ||||
EnerSys | 14,794 | 1,167,838 | ||||
Sensata Technologies Holding NV(NON)(S) | 17,800 | 777,326 | ||||
2,400,637 | ||||||
Electronic equipment, instruments, and components (2.1%) | ||||||
Belden, Inc. | 5,900 | 408,221 | ||||
Littelfuse, Inc. | 5,438 | 869,591 | ||||
MTS Systems Corp. | 6,318 | 347,806 | ||||
Plexus Corp.(NON) | 14,234 | 822,725 | ||||
SYNNEX Corp. | 6,525 | 730,409 | ||||
3,178,752 | ||||||
Equity real estate investment trusts (REITs) (1.9%) | ||||||
Chesapeake Lodging Trust | 18,200 | 436,072 | ||||
National Health Investors, Inc. | 11,879 | 862,772 | ||||
Ryman Hospitality Properties | 6,600 | 408,078 | ||||
STAG Industrial, Inc. | 25,300 | 633,006 | ||||
Uniti Group, Inc. | 22,566 | 583,331 | ||||
2,923,259 | ||||||
Food products (0.3%) | ||||||
Nomad Foods, Ltd. (United Kingdom)(NON) | 42,149 | 482,606 | ||||
482,606 | ||||||
Health-care equipment and supplies (5.3%) | ||||||
Conmed Corp. | 9,828 | 436,461 | ||||
DexCom, Inc.(NON) | 6,522 | 552,609 | ||||
GenMark Diagnostics, Inc.(NON) | 58,929 | 755,470 | ||||
Globus Medical, Inc. Class A(NON) | 13,621 | 403,454 | ||||
Halyard Health, Inc.(NON) | 8,800 | 335,192 | ||||
ICU Medical, Inc.(NON) | 9,417 | 1,437,976 | ||||
Integer Holdings Corp.(NON) | 18,314 | 736,223 | ||||
Integra LifeSciences Holdings Corp.(NON) | 14,800 | 623,524 | ||||
NuVasive, Inc.(NON) | 4,400 | 328,592 | ||||
Penumbra, Inc.(NON)(S) | 13,425 | 1,120,316 | ||||
Spectranetics Corp. (The)(NON) | 24,217 | 705,320 | ||||
STERIS PLC (United Kingdom) | 9,728 | 675,707 | ||||
8,110,844 | ||||||
Health-care providers and services (2.2%) | ||||||
Envision Healthcare Corp.(NON) | 5,480 | 336,034 | ||||
HealthEquity, Inc.(NON) | 22,500 | 955,125 | ||||
HealthSouth Corp. | 13,604 | 582,387 | ||||
Landauer, Inc. | 9,750 | 475,313 | ||||
Molina Healthcare, Inc.(NON)(S) | 3,559 | 162,290 | ||||
PharMerica Corp.(NON) | 6,547 | 153,200 | ||||
Premier, Inc. Class A(NON) | 19,800 | 630,234 | ||||
3,294,583 | ||||||
Health-care technology (2.0%) | ||||||
Evolent Health, Inc. Class A(NON)(S) | 74,300 | 1,656,890 | ||||
Veeva Systems, Inc. Class A(NON)(S) | 27,852 | 1,428,251 | ||||
3,085,141 | ||||||
Hotels, restaurants, and leisure (2.1%) | ||||||
Carrols Restaurant Group, Inc.(NON) | 10,800 | 152,820 | ||||
Cedar Fair LP | 9,093 | 616,596 | ||||
Cheesecake Factory, Inc. (The) | 10,053 | 636,958 | ||||
Marcus Corp. (The) | 9,605 | 308,321 | ||||
Penn National Gaming, Inc.(NON) | 27,300 | 503,139 | ||||
Wyndham Worldwide Corp. | 12,100 | 1,019,909 | ||||
3,237,743 | ||||||
Household durables (1.6%) | ||||||
CalAtlantic Group, Inc. | 13,200 | 494,340 | ||||
Century Communities, Inc.(NON) | 15,000 | 381,000 | ||||
Ethan Allen Interiors, Inc. | 10,371 | 317,871 | ||||
Installed Building Products, Inc.(NON) | 2,242 | 118,266 | ||||
LGI Homes, Inc.(NON)(S) | 32,100 | 1,088,511 | ||||
2,399,988 | ||||||
Insurance (0.3%) | ||||||
Amtrust Financial Services, Inc. | 25,799 | 476,250 | ||||
476,250 | ||||||
Internet and direct marketing retail (0.5%) | ||||||
FTD Cos., Inc.(NON) | 16,400 | 330,296 | ||||
Groupon, Inc.(NON)(S) | 111,400 | 437,802 | ||||
768,098 | ||||||
Internet software and services (5.3%) | ||||||
2U, Inc.(NON)(S) | 22,600 | 896,316 | ||||
Amber Road, Inc.(NON) | 50,300 | 388,316 | ||||
Blucora, Inc.(NON) | 40,800 | 705,840 | ||||
Box, Inc. Class A(NON)(S) | 40,200 | 655,662 | ||||
Carbonite, Inc.(NON) | 49,700 | 1,008,910 | ||||
Envestnet, Inc.(NON) | 4,800 | 155,040 | ||||
Instructure, Inc.(NON) | 36,700 | 858,780 | ||||
J2 Cloud Services, LLC(S) | 13,300 | 1,116,003 | ||||
New Relic, Inc.(NON)(S) | 13,300 | 493,031 | ||||
Shopify, Inc. Class A (Canada)(NON) | 15,700 | 1,069,013 | ||||
Stamps.com, Inc.(NON) | 6,200 | 733,770 | ||||
8,080,681 | ||||||
IT Services (0.6%) | ||||||
Convergys Corp. | 19,600 | 414,540 | ||||
Hackett Group, Inc. (The) | 21,700 | 422,933 | ||||
837,473 | ||||||
Leisure products (0.9%) | ||||||
Brunswick Corp. | 15,800 | 966,960 | ||||
MCBC Holdings, Inc. | 21,088 | 340,993 | ||||
1,307,953 | ||||||
Life sciences tools and services (2.1%) | ||||||
Albany Molecular Research, Inc.(NON)(S) | 39,300 | 551,379 | ||||
Cambrex Corp.(NON) | 14,234 | 783,582 | ||||
Charles River Laboratories International, Inc.(NON) | 8,699 | 782,475 | ||||
INC Research Holdings, Inc. Class A(NON) | 10,153 | 465,515 | ||||
VWR Corp.(NON) | 20,100 | 566,820 | ||||
3,149,771 | ||||||
Machinery (4.5%) | ||||||
Altra Industrial Motion Corp. | 14,552 | 566,800 | ||||
Columbus McKinnon Corp./NY | 23,800 | 590,716 | ||||
Greenbrier Cos., Inc. (The)(S) | 20,300 | 874,930 | ||||
Hillenbrand, Inc. | 20,900 | 749,265 | ||||
Kadant, Inc. | 11,248 | 667,569 | ||||
Standex International Corp. | 11,957 | 1,197,494 | ||||
Wabash National Corp. | 33,792 | 699,156 | ||||
Wabtec Corp.(S) | 5,300 | 413,400 | ||||
Woodward, Inc. | 15,718 | 1,067,567 | ||||
6,826,897 | ||||||
Marine (0.2%) | ||||||
Matson, Inc. | 10,234 | 325,032 | ||||
325,032 | ||||||
Media (1.0%) | ||||||
IMAX Corp. (Canada)(NON) | 9,300 | 316,200 | ||||
Liberty Media Corp.-Liberty SiriusXM Class C(NON) | 12,600 | 488,628 | ||||
Regal Entertainment Group Class A(S) | 32,719 | 738,795 | ||||
1,543,623 | ||||||
Metals and mining (1.0%) | ||||||
AK Steel Holding Corp.(NON) | 33,900 | 243,741 | ||||
Reliance Steel & Aluminum Co. | 12,800 | 1,024,256 | ||||
United States Steel Corp. | 9,300 | 314,433 | ||||
1,582,430 | ||||||
Multiline retail (0.2%) | ||||||
Big Lots, Inc. | 6,800 | 331,024 | ||||
331,024 | ||||||
Oil, gas, and consumable fuels (1.5%) | ||||||
Callon Petroleum Co.(NON) | 46,970 | 618,125 | ||||
Gulfport Energy Corp.(NON) | 15,620 | 268,508 | ||||
Ring Energy, Inc.(NON) | 56,600 | 612,412 | ||||
SRC Energy, Inc.(NON)(S) | 88,600 | 747,784 | ||||
2,246,829 | ||||||
Paper and forest products (0.6%) | ||||||
KapStone Paper and Packaging Corp. | 38,169 | 881,704 | ||||
881,704 | ||||||
Personal products (0.3%) | ||||||
Nutraceutical International Corp. | 16,508 | 514,224 | ||||
514,224 | ||||||
Pharmaceuticals (3.4%) | ||||||
Aerie Pharmaceuticals, Inc.(NON) | 4,100 | 185,935 | ||||
ANI Pharmaceuticals, Inc.(NON) | 7,400 | 366,374 | ||||
Cardiome Pharma Corp. (Canada)(NON) | 97,124 | 291,372 | ||||
Horizon Pharma PLC(NON) | 40,700 | 601,546 | ||||
Impax Laboratories, Inc.(NON) | 12,509 | 158,239 | ||||
Jazz Pharmaceuticals PLC(NON) | 8,482 | 1,230,993 | ||||
Lannett Co., Inc.(NON)(S) | 11,444 | 255,773 | ||||
Medicines Co. (The)(NON)(S) | 16,900 | 826,410 | ||||
Pacira Pharmaceuticals, Inc.(NON)(S) | 12,562 | 572,827 | ||||
Prestige Brands Holdings, Inc.(NON) | 7,767 | 431,535 | ||||
Sucampo Pharmaceuticals, Inc. Class A(NON) | 26,833 | 295,163 | ||||
5,216,167 | ||||||
Professional services (0.9%) | ||||||
ICF International, Inc.(NON) | 21,500 | 887,950 | ||||
WageWorks, Inc.(NON) | 7,089 | 512,535 | ||||
1,400,485 | ||||||
Real estate management and development (0.6%) | ||||||
RE/MAX Holdings, Inc. Class A | 16,174 | 961,544 | ||||
961,544 | ||||||
Road and rail (0.7%) | ||||||
Saia, Inc.(NON) | 24,200 | 1,072,060 | ||||
1,072,060 | ||||||
Semiconductors and semiconductor equipment (9.9%) | ||||||
Advanced Energy Industries, Inc.(NON) | 19,448 | 1,333,355 | ||||
Ambarella, Inc.(NON) | 7,241 | 396,155 | ||||
Cavium, Inc.(NON) | 9,300 | 666,438 | ||||
CEVA, Inc.(NON) | 37,792 | 1,341,616 | ||||
Cirrus Logic, Inc.(NON) | 5,731 | 347,814 | ||||
FormFactor, Inc.(NON) | 79,400 | 940,890 | ||||
Inphi Corp.(NON) | 10,900 | 532,138 | ||||
Integrated Device Technology, Inc.(NON) | 31,328 | 741,534 | ||||
MaxLinear, Inc. Class A(NON) | 31,700 | 889,185 | ||||
Microsemi Corp.(NON) | 16,212 | 835,404 | ||||
MKS Instruments, Inc. | 17,861 | 1,227,944 | ||||
Monolithic Power Systems, Inc. | 12,088 | 1,113,305 | ||||
ON Semiconductor Corp.(NON) | 61,482 | 952,356 | ||||
Power Integrations, Inc. | 10,577 | 695,438 | ||||
Semtech Corp.(NON) | 8,512 | 287,706 | ||||
Silicon Laboratories, Inc.(NON) | 5,734 | 421,736 | ||||
Teradyne, Inc. | 17,600 | 547,360 | ||||
Tower Semiconductor, Ltd. (Israel)(NON)(S) | 57,600 | 1,327,674 | ||||
Xperi Corp. | 17,002 | 577,218 | ||||
15,175,266 | ||||||
Software (6.5%) | ||||||
A10 Networks, Inc.(NON) | 53,178 | 486,579 | ||||
Aspen Technology, Inc.(NON) | 14,735 | 868,186 | ||||
CommVault Systems, Inc.(NON) | 11,400 | 579,120 | ||||
Fortinet, Inc.(NON) | 20,600 | 790,010 | ||||
Gigamon, Inc.(NON) | 13,231 | 470,362 | ||||
MobileIron, Inc.(NON) | 69,236 | 301,177 | ||||
Proofpoint, Inc.(NON) | 9,721 | 722,854 | ||||
PROS Holdings, Inc.(NON) | 31,100 | 752,309 | ||||
QAD, Inc. Class A | 33,269 | 926,542 | ||||
RealPage, Inc.(NON) | 26,500 | 924,850 | ||||
ServiceNow, Inc.(NON) | 7,900 | 691,013 | ||||
Take-Two Interactive Software, Inc.(NON) | 9,400 | 557,138 | ||||
Tyler Technologies, Inc.(NON) | 5,035 | 778,210 | ||||
Verint Systems, Inc.(NON) | 14,086 | 610,980 | ||||
Zendesk, Inc.(NON) | 15,700 | 440,228 | ||||
9,899,558 | ||||||
Specialty retail (1.2%) | ||||||
American Eagle Outfitters, Inc. | 34,900 | 489,647 | ||||
Chico's FAS, Inc. | 24,900 | 353,580 | ||||
Children's Place, Inc. (The) | 7,100 | 852,355 | ||||
MarineMax, Inc.(NON) | 7,010 | 151,767 | ||||
1,847,349 | ||||||
Technology hardware, storage, and peripherals (1.8%) | ||||||
Cray, Inc.(NON) | 26,300 | 575,970 | ||||
NCR Corp.(NON) | 28,700 | 1,311,016 | ||||
Pure Storage, Inc. Class A(NON) | 27,000 | 265,410 | ||||
Super Micro Computer, Inc.(NON) | 21,700 | 550,095 | ||||
2,702,491 | ||||||
Textiles, apparel, and luxury goods (1.1%) | ||||||
Oxford Industries, Inc. | 5,414 | 310,006 | ||||
Perry Ellis International, Inc.(NON) | 20,800 | 446,784 | ||||
Steven Madden, Ltd.(NON) | 12,444 | 479,716 | ||||
Wolverine World Wide, Inc. | 17,101 | 427,012 | ||||
1,663,518 | ||||||
Thrifts and mortgage finance (1.1%) | ||||||
BofI Holding, Inc.(NON)(S) | 27,467 | 717,713 | ||||
Essent Group, Ltd.(NON) | 26,689 | 965,341 | ||||
1,683,054 | ||||||
Tobacco (0.3%) | ||||||
Vector Group, Ltd.(S) | 19,916 | 414,253 | ||||
414,253 | ||||||
Trading companies and distributors (0.3%) | ||||||
Beacon Roofing Supply, Inc.(NON) | 9,924 | 487,864 | ||||
487,864 | ||||||
Total common stocks (cost $118,615,316) | $149,608,690 | |||||
SHORT-TERM INVESTMENTS (13.6%)(a) | ||||||
Shares | Value | |||||
Putnam Cash Collateral Pool, LLC 1.03%(AFF) | 20,342,255 | $20,342,255 | ||||
Putnam Short Term Investment Fund 0.87%(AFF) | 372,168 | 372,168 | ||||
Total short-term investments (cost $20,714,423) | $20,714,423 | |||||
TOTAL INVESTMENTS | ||||||
Total investments (cost $139,329,739)(b) | $170,323,113 | |||||
Notes to the fund's portfolio | ||||||
Unless noted otherwise, the notes to the fund's portfolio are for the close of the fund's reporting period, which ran from July 1, 2016 through March 31, 2017 (the reporting period). Within the following notes to the portfolio, references to "ASC 820" represent Accounting Standards Codification 820 Fair Value Measurements and Disclosures, references to "Putnam Management" represent Putnam Investment Management, LLC, the fund's manager, an indirect wholly-owned subsidiary of Putnam Investments, LLC and references to "OTC", if any, represent over-the-counter. | ||||||
(a) | Percentages indicated are based on net assets of $152,180,153. | |||||
(b) | The aggregate identified cost on a tax basis is $139,331,720, resulting in gross unrealized appreciation and depreciation of $35,615,130 and $4,623,737, respectively, or net unrealized appreciation of $30,991,393. | |||||
(NON) | This security is non-income-producing. | |||||
(AFF) | Affiliated company. For investments in Putnam Cash Collateral Pool, LLC and Putnam Short Term Investment Fund, the rate quoted in the security description is the annualized 7-day yield of the fund at the close of the reporting period. Transactions during the period with any company which is under common ownership or control were as follows: | |||||
Name of affiliate | Fair value at the beginning of the reporting period | Purchase cost | Sale proceeds | Investment income | Fair value at the end of the reporting period | |
Putnam Cash Collateral Pool, LLC*# | $18,919,737 | $70,624,034 | $69,201,516 | $135,867 | $20,342,255 | |
Putnam Short Term Investment Fund** | 2,996,245 | 36,375,092 | 38,999,169 | 8,033 | 372,168 | |
Totals | $21,915,982 | $106,999,126 | $108,200,685 | $143,900 | $20,714,423 | |
* No management fees are charged to Putnam Cash Collateral Pool, LLC. | ||||||
# The fund may lend securities, through its agent, to qualified borrowers in order to earn additional income. The loans are collateralized by cash in an amount at least equal to the fair value of the securities loaned. The fair value of securities loaned is determined daily and any additional required collateral is allocated to the fund on the next business day. The remaining maturities of the securities lending transactions are considered overnight and continuous. The risk of borrower default will be borne by the fund's agent; the fund will bear the risk of loss with respect to the investment of the cash collateral. The fund received cash collateral of $20,342,255, which is invested in Putnam Cash Collateral Pool, LLC, a limited liability company managed by an affiliate of Putnam Management. Investments in Putnam Cash Collateral Pool, LLC are valued at its closing net asset value each business day. There are no management fees charged to Putnam Cash Collateral Pool, LLC. The rate quoted in the security description is the annualized 7-day yield at the close of the reporting period. At the close of the reporting period, the value of securities loaned amounted to $19,860,624. Certain of these securities were sold prior to the close of the reporting period. | ||||||
** Management fees charged to Putnam Short Term Investment Fund have been waived by Putnam Management. | ||||||
(S) | This security is on loan, in part or in entirety, at the close of the reporting period. | |||||
Security valuation: Portfolio securities and other investments are valued using policies and procedures adopted by the Board of Trustees. The Trustees have formed a Pricing Committee to oversee the implementation of these procedures and have delegated responsibility for valuing the fund's assets in accordance with these procedures to Putnam Management. Putnam Management has established an internal Valuation Committee that is responsible for making fair value determinations, evaluating the effectiveness of the pricing policies of the fund and reporting to the Pricing Committee. | ||||||
Investments for which market quotations are readily available are valued at the last reported sales price on their principal exchange, or official closing price for certain markets, and are classified as Level 1 securities under ASC 820. If no sales are reported, as in the case of some securities that are traded OTC, a security is valued at its last reported bid price and is generally categorized as a Level 2 security. | ||||||
Investments in open-end investment companies (excluding exchange-traded funds), if any, which can be classified as Level 1 or Level 2 securities, are valued based on their net asset value. The net asset value of such investment companies equals the total value of their assets less their liabilities and divided by the number of their outstanding shares. | ||||||
Many securities markets and exchanges outside the U.S. close prior to the scheduled close of the New York Stock Exchange and therefore the closing prices for securities in such markets or on such exchanges may not fully reflect events that occur after such close but before the scheduled close of the New York Stock Exchange. Accordingly, on certain days, the fund will fair value certain foreign equity securities taking into account multiple factors including movements in the U.S. securities markets, currency valuations and comparisons to the valuation of American Depository Receipts, exchange-traded funds and futures contracts. The foreign equity securities, which would generally be classified as Level 1 securities, will be transferred to Level 2 of the fair value hierarchy when they are valued at fair value. The number of days on which fair value prices will be used will depend on market activity and it is possible that fair value prices will be used by the fund to a significant extent. Securities quoted in foreign currencies, if any, are translated into U.S. dollars at the current exchange rate. Short-term securities with remaining maturities of 60 days or less are valued using an independent pricing service approved by the Trustees, and are classified as Level 2 securities. | ||||||
To the extent a pricing service or dealer is unable to value a security or provides a valuation that Putnam Management does not believe accurately reflects the security's fair value, the security will be valued at fair value by Putnam Management in accordance with policies and procedures approved by the Trustees. Certain investments, including certain restricted and illiquid securities and derivatives, are also valued at fair value following procedures approved by the Trustees. These valuations consider such factors as significant market or specific security events such as interest rate or credit quality changes, various relationships with other securities, discount rates, U.S. Treasury, U.S. swap and credit yields, index levels, convexity exposures, recovery rates, sales and other multiples and resale restrictions. These securities are classified as Level 2 or as Level 3 depending on the priority of the significant inputs. | ||||||
To assess the continuing appropriateness of fair valuations, the Valuation Committee reviews and affirms the reasonableness of such valuations on a regular basis after considering all relevant information that is reasonably available. Such valuations and procedures are reviewed periodically by the Trustees. The fair value of securities is generally determined as the amount that the fund could reasonably expect to realize from an orderly disposition of such securities over a reasonable period of time. By its nature, a fair value price is a good faith estimate of the value of a security in a current sale and does not reflect an actual market price, which may be different by a material amount. |
ASC 820 establishes a three-level hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of the fund's investments. The three levels are defined as follows: | ||||
Level 1: Valuations based on quoted prices for identical securities in active markets. | ||||
Level 2: Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. | ||||
Level 3: Valuations based on inputs that are unobservable and significant to the fair value measurement. | ||||
The following is a summary of the inputs used to value the fund's net assets as of the close of the reporting period: | ||||
Valuation inputs | ||||
| ||||
Investments in securities: | Level 1 | Level 2 | Level 3 | |
Common stocks*: | ||||
Consumer discretionary | $13,987,513 | $— | $— | |
Consumer staples | 1,411,083 | — | — | |
Energy | 2,246,829 | — | — | |
Financials | 10,066,467 | — | — | |
Health care | 34,507,906 | — | — | |
Industrials | 28,194,602 | — | — | |
Information technology | 44,423,063 | — | — | |
Materials | 9,592,622 | — | — | |
Real estate | 3,884,803 | — | — | |
Telecommunication services | 1,293,802 | — | — | |
Total common stocks | 149,608,690 | — | — | |
Short-term investments | 372,168 | 20,342,255 | — | |
|
|
|
||
Totals by level | $149,980,858 | $20,342,255 | $— | |
* Common stock classifications are presented at the sector level, which may differ from the fund's portfolio presentation. | ||||
During the reporting period, transfers within the fair value hierarchy, if any (other than certain transfers involving non-U.S. equity securities as described in the Security valuation note above), did not represent, in the aggregate, more than 1% of the fund's net assets measured as of the end of the period. Transfers are accounted for using the end of period pricing valuation method. | ||||
For additional information regarding the fund please see the fund's most recent annual or semiannual shareholder report filed on the Securities and Exchange Commission's Web site, www.sec.gov, or visit Putnam's Individual Investor Web site at www.putnaminvestments.com |
Item 2. Controls and Procedures: |
(a) The registrant's principal executive officer and principal financial officer have concluded, based on their evaluation of the effectiveness of the design and operation of the registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the design and operation of such procedures are generally effective to provide reasonable assurance that information required to be disclosed by the registrant in this report is recorded, processed, summarized and reported within the time periods specified in the Commission's rules and forms. |
(b) Changes in internal control over financial reporting: Not applicable |
Item 3. Exhibits: |
Separate certifications for the principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Investment Company Act of 1940, as amended, are filed herewith. |
SIGNATURES |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. |
Putnam Funds Trust |
By (Signature and Title): |
/s/ Janet C. Smith Janet C. Smith Principal Accounting Officer Date: May 26, 2017 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. |
By (Signature and Title): |
/s/ Jonathan S. Horwitz Jonathan S. Horwitz Principal Executive Officer Date: May 26, 2017 |
By (Signature and Title): |
/s/ Janet C. Smith Janet C. Smith Principal Financial Officer Date: May 26, 2017 |
Certifications | |
I, Jonathan S. Horwitz, the Principal Executive Officer of the funds listed on Attachment A, certify that: | |
1. I have reviewed each report on Form N-Q of the funds listed on Attachment A: | |
2. Based on my knowledge, each report does not contain any untrue statements of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by each report; | |
3. Based on my knowledge, the schedules of investments included in each report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; | |
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrants and have: | |
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which each report is being prepared; | |
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and | |
d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |
5. The registrant's other certifying officer and I have disclosed to each registrant's auditors and the audit committee of each registrant's board of directors (or persons performing the equivalent functions): | |
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect each registrant's ability to record, process, summarize, and report financial information; and | |
b) any fraud, whether or not material, that involves management or other employees who have a significant role in each registrant's internal control over financial reporting. | |
/s/ Jonathan S. Horwitz | |
_____________________________ | |
Date: May 25, 2017 | |
Jonathan S. Horwitz | |
Principal Executive Officer | |
Certifications | |
I, Janet C. Smith, the Principal Financial Officer of the funds listed on Attachment A, certify that: | |
1. I have reviewed each report on Form N-Q of the funds listed on Attachment A: | |
2. Based on my knowledge, each report does not contain any untrue statements of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by each report; | |
3. Based on my knowledge, the schedules of investments included in each report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; | |
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrants and have: | |
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which each report is being prepared; | |
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and | |
d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |
5. The registrant's other certifying officer and I have disclosed to each registrant's auditors and the audit committee of each registrant's board of directors (or persons performing the equivalent functions): | |
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect each registrant's ability to record, process, summarize, and report financial information; and | |
b) any fraud, whether or not material, that involves management or other employees who have a significant role in each registrant's internal control over financial reporting. | |
/s/ Janet C. Smith | |
_______________________________ | |
Date: May 25, 2017 | |
Janet C. Smith | |
Principal Financial Officer | |
Attachment A | |
NQ | |
Period (s) ended March 31, 2017 | |
Putnam Europe Equity Fund | |
Putnam International Equity Fund | |
Putnam Multi-Cap Growth Fund | |
Putnam Small Cap Growth Fund | |
Putnam International Value Fund | |
Putnam VT Absolute 500 Fund | |
Putnam VT American Government Income Fund | |
Putnam VT Capital Opportunities Fund | |
Putnam VT Diversified Income Fund | |
Putnam VT Equity Income Fund | |
Putnam VT George Putnam Balanced Fund | |
Putnam VT Global Asset Allocation Fund | |
Putnam VT Global Equity Fund | |
Putnam VT Global Health Care Fund | |
Putnam VT Global Utilities Fund | |
Putnam VT Growth and Income Fund | |
Putnam VT Growth Opportunities Fund | |
Putnam VT High Yield Fund | |
Putnam VT Income Fund | |
Putnam VT International Equity Fund | |
Putnam VT International Value Fund | |
Putnam VT International Growth Fund | |
Putnam VT Investors Fund | |
Putnam VT Multi-Cap Value Fund | |
Putnam VT Government Money Market Fund | |
Putnam VT Multi-Cap Growth Fund | |
Putnam VT Research Fund | |
Putnam VT Small Cap Value Fund |